Our system has noticed that you are based in , but the current country setting is . Select country

  1. Home
  2. Company
  3. WACKER Global
  4. North America
  5. About us

About Us

WACKER formulations are so versatile and adaptable, they have virtually unlimited applications in products ranging from chewing gum and air fresheners to computer chips and cosmetics, making WACKER an integral part of daily life.

About WACKER

Wacker Chemical Corporation (WCC) is the North American subsidiary of our global company, Wacker Chemie AG. We’ve been manufacturing silicones since 1969 in North America – one of WACKER’s fastest growing and most important forward-looking markets. In 2022, we established our Innovation Center and Regional Headquarters in Ann Arbor, Michigan, to better serve our customers.

Sales in the Americas have increased 2.3 percent to €1.07 billion (2023: €1.04 billion) and accounted for 18.6 percent of Group sales (2023: 16.3 percent).

We manufacture:

  • Silicones at our plant in Adrian, Michigan.
  • Polysilicon at our site in Charleston, Tennessee.
  • Polymers in Calvert City, Kentucky.
  • Biosolutions in Eddyville, Iowa.
  • Biotech in San Diego, California, at Wacker Biotech US Inc.
  • Silicone mixtures under the SILMIX® trademark at our plants in N. Canton, Ohio, and Chino, California.
  • Silicone-coated adhesive products at Wacker Silicone Manufactured Innovations LLC in Allentown, Pennsylvania.

Production Sites

Adrian, Michigan
Allentown, Pennsylvania
Calvert City, Kentucky
Charleston, Tennessee
Chino, California
Eddyville, Iowa
North Canton, Ohio
San Diego, California
Portrait of Dr. Christoph Kowitz, president and CEO of Wacker Chemical Corporation

Dr. Christoph Kowitz, president and CEO of Wacker Chemical Corporation

President’s Message

Innovation. Customer access. Investments in research, equipment and facilities. World-class laboratories. And the best team.

These are some of the key ingredients to achieving success in North America - one of WACKER’s fastest growing and most important forward-looking markets globally.

Wacker Chemical Corporation (WCC) – the North American subsidiary of Wacker Chemie AG - is a results-based business providing customers with customizable, value-creating solutions.

To meet our customers’ needs, we must develop the best possible economical, high-quality products. And to do that, we need the best team in the industry – and I’m proud to call them my colleagues.

But none of that matters if we don’t live up to the highest safety standards. At WACKER, safety is the precondition for everything we do. We never stop looking for ways to work more safely so our employees can go home and return the next day to do what we do best - creating tomorrow’s solutions.

Our robust presence throughout the Americas includes eight production plants, five tech centers and sales offices, 21 distributors, and a variety of R&D initiatives and application laboratories.

We manufacture silicones at our plant in Adrian, MI, polysilicon at our site in Charleston, TN, polymers in Calvert City, KY, biosolutions in Eddyville, IA, biotech manufacturing in San Diego, CA, and run silicone mixing operations under the SILMIX® trademark in N. Canton, OH, and Chino, CA.

I am proud of what we have done so far in the Americas, and look forward to continuing to collaborate, innovate and serve our customers to embrace the incredible opportunities that lie ahead.

cafeteria
WACKER in Dalton, Georgia
Food Labor
Chemist
Wacker Allentown

The Numbers Behind the Success Story

Icon line chart
Increase in sales in the Americas
Icon research
Invested in R&D in the Americas
Icon Production plant
VAE capacity at the Calvert City, KY, polymers production plant
Icon capacity
Capacity in San Diego for cGMP production and purification

Pharmaceutical Manufacturing in the US

Pharmaceutical Manufacturing in the US - lab scene

In 2021, WACKER strengthened its business by adding a pharmaceutical contract development and manufacturing organization (CDMO) location for plasmid DNA (pDNA) based in San Diego, Calif. The demand for pDNA has risen sharply in recent years. This new WACKER location includes a capacity up to 650 liters for the production and purification of pDNA. For decades, WACKER has been manufacturing therapeutic proteins, living microbial products and vaccines for clinical development as well as commercial supply. This proprietary pDNA technology enhances WACKER's portfolio and creates a US presence in serving as a contract manufacturer for the pharmaceutical industry.

Wacker Biotech